Simon Claridge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Simon Claridge has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Angela Lee
1 shared publicationAnoop Shetty
1 shared publication- Anthony Dorling
Department of Inflammation Biology, School of Immunology & Microbial Sciences, King’s College London, Guy’s Hospital, London, United Kingdom
1 shared publication Christopher Aldo Rinaldi
1 shared publication- Christopher Aldo Rinaldi
Guy’s and St Thomas’ Hospital & School of Biomedical Engineering and Imaging Sciences, King’s College London Department of Cardiology Westminster Bridge Road, London SE1 7EH
1 shared publication Eoin Hyde
1 shared publication
Latest Publications
- 1 December 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (12) , 2089-2090
A rare complication from transseptal puncture-persistent aorto-right atrial shunt and puncture of noncoronary cusp of aortic valve
- 1 December 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (12) , 2089-2090
A rare complication from transseptal puncture-persistent aorto-right atrial shunt and puncture of noncoronary cusp of aortic valve
- 15 March 2011
- Published by BMJ in BMJ Case Reports
- Vol. 2011
Plasmapheresis as rescue therapy for systemic lupus erthyematosus-associated diffuse alveolar haemorrhage
Diffuse alveolar haemorrhage (DAH) is a rare complication of systemic lupus erythematosus (SLE), which can have a potentially lethal outcome. Conventional treatments of the condition include cyclophosphamide and intravenous immunoglobulins. Successful treatment with rituximab and plasmapheresis has also been described. The authors report the case of a woman recently diagnosed with SLE who developed DAH refractory to conventional treatment while on immunosuppressive treatment for class III lupus nephritis whose DAH responded to plasmapheresis.
- 15 March 2011
- Published by BMJ in BMJ Case Reports
- Vol. 2011
Plasmapheresis as rescue therapy for systemic lupus erthyematosus-associated diffuse alveolar haemorrhage
Diffuse alveolar haemorrhage (DAH) is a rare complication of systemic lupus erythematosus (SLE), which can have a potentially lethal outcome. Conventional treatments of the condition include cyclophosphamide and intravenous immunoglobulins. Successful treatment with rituximab and plasmapheresis has also been described. The authors report the case of a woman recently diagnosed with SLE who developed DAH refractory to conventional treatment while on immunosuppressive treatment for class III lupus nephritis whose DAH responded to plasmapheresis.